BackgroundCardiac output (CO) is an important haemodynamic parameter to monitor in patients during surgery. However, the majority of the techniques for measuring CO have a limited application in veterinary practice due to their invasive approach and associated complexity and risks. Transoesophageal echocardiography (TEE) is a technique used to monitor cardiac function in human patients during surgical procedures and allows CO to be measured non-invasively. This prospective clinical study aimed to compare the transoesophageal echocardiography using a transgastric view of the left ventricular outflow tract (LVOT) and the thermodilution (TD) technique for the assessment of CO during mean arterial pressure of 65–80 mmHg (normotension) and <65 mmHg (hypotension) in dogs undergoing elective surgery. Eight dogs were pre-medicated with acepromazine (0.05 mg/kg, IM), tramadol (4 mg/kg, IM) and atropine (0.03 mg/kg, IM), followed by anaesthetic induction with propofol (3–5 mg/kg IV) and maintenance with isoflurane associated with a continuous infusion rate of fentanyl (bolus of 3 μg/kg followed by 0.3 μg/kg/min). The CO was measured by TEE (COTEE) and TD (COTD) at the end of expiration during normotension and hypotension (induced by isoflurane).ResultsThere was a strong positive correlation between COTEE and COTD (r = 0.925; P < 0.0001). The bias between COTD and COTEE was 0.14 ± 0.29 L/min (limits of agreement, −0.44 to 0.72 L/min). The percentage error of CO measured by the two methods was 12.32%. In addition, a strong positive correlation was found between COTEE and COTD during normotension (r = 0.995; P < 0.0001) and hypotension (r = 0.78; P = 0.0223).ConclusionsThe results of this study indicated that the transgastric view of the LVOT by TEE was a minimally invasive alternative to clinically monitoring CO in dogs during anaesthesia. However, during hypotension, the CO obtained by TEE was less reliable, although still acceptable.
The aim of this paper was to compare the incidence of anesthetic complications in diabetic and nondiabetic dogs subjected to phacoemulsification. In total, 30 male and female dogs of different breeds were used. The dogs were distributed into two groups: diabetic (DG) (n=15) and control (CG) (n=15). The animals were premedicated with acepromazine (0.03mg/kg) and meperidine (4mg/kg), intramuscularly. After 20 minutes, anesthesia was induced with propofol (2 to 5mg/kg) and maintained with isoflurane. The animals were monitored and the heart rate, respiratory rate, peripheral oxyhemoglobin saturation, end tidal carbon dioxide tension, inspired and expired isoflurane fraction, and invasive arterial pressure were recorded at 10 minute intervals during the surgical procedure. Arterial hemogasometry was performed after anesthetic induction (T0) and at the end of the surgical procedure. Diabetic patients (DG 10±2 years) were older than non-diabetic group (CG 6±2 years). The expired isoflurane fraction after induction was 30% higher in the control group (CG 1.3±0.3%, DG 1.0±0.2%) (p<0.01). The most common anesthetic complication was hypotension. In total, 80% of the diabetic animals (n=12) exhibited mean arterial pressure (MAP) lower than 60mmHg (54±9.6mmHg) after anesthetic induction, and 83% of the hypotensive dogs (n=10) required vasoactive drugs to treat hypotension. Regarding hemodynamic changes, diabetic patients subjected to general anesthesia were more likely to exhibit hypotension which may be due to the response of older animals to the drugs used; however, this change deserves further investigation.
Lung lobe torsion is one of the causes of dyspnea and respiratory changes in dogs. Twisting of the bronchovascular hilum on its axis, leads to loss of function and metabolic and physiological changes that result in necrosis of the affected lobe. Atelectasis, venous congestion, and pleural effusion secondary to the lobe torsion are responsible for the clinical signs. Chest radiographs or CT scan are used to confirm the diagnosis. In rare cases confirmation is done by exploratory thoracotomy. The prognosis is good after removal of the affected lung lobe. We report a case of left cranial lung lobe torsion in a 17-year-old bitch, successfully treated by lung lobectomy.
The objective of this study was to compare the dosages for anesthesia induction in obese dogs using propofol based on lean body weight or total body weight. For this purpose, seven dogs with ideal body condition score (BCS) (BCS 4-5; 17.3 ± 2.5% fat mass) were included in the control group (CG), seven obese dogs (BCS 8-9; 45.7 ± 2.9% fat mass) in the total body weight group (TBWG) and seven obese dogs (BCS 8-9; 42.8 ± 6.3% fat mass) in the lean body weight group (LBWG). Anaesthesia was induced by a constant rate infusion of propofol at 150 mg kg
−1
hour
−1
through a propofol infusion pump until the loss of consciousness; the animals in CG and TBWG received a propofol infusion based on total body weight; the animals in LBWG received a propofol infusion based on lean body mass (in kg) determined by the deuterium dilution method. The results were compared between the groups using the Tukey test (
p
< 0.05). The propofol dosage used was 11.4 ± 3.2 mg kg
−1
, 8.0± 2.0 mg kg
−1
and 14.1 ± 4.7 mg kg
−1
in groups CG, TBWG and LBWG, respectively, and they were different among all groups (
p
< 0.001). There was also a statistical difference in the time between the start of propofol infusion and loss of consciousness in which LBWG took longer than CG and TBWG (
p
= 0.004). This study shows that obese dogs require lower dosages of propofol when inducing anesthesia than ideal BCS dogs anesthetized with dosages based on total body weight, when the propofol dosages are calculated on the basis of muscle mass it should be increased.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.